As compared to normal tissues, bladder, breast, colon, liver, prostate, and lung cancers showed higher expression of p32, whereas kidney, thyroid, pheochromocytoma, and paraganglioma tumors showed lower expression of p32 (Figure S1A). This evidence concerns the gene C1QBP and paraganglioma.